Exportin 1 inhibition attenuates nuclear factor-kappaB-dependent gene expression

Area of Science:

• Cellular and Molecular Biology
• Immunology
• Endothelial Cell Biology

Background:

• Nuclear factor-kappaB (NF-kappaB) activation is crucial for inflammatory responses.
• NF-kappaB signaling involves IkappaBalpha phosphorylation, degradation, and nuclear translocation.
• Nuclear exportin 1 regulates the nuclear export of IkappaBalpha and NF-kappaB complexes.

Purpose of the Study:

• To investigate the role of exportin 1 in regulating NF-kappaB signaling in pulmonary microvascular endothelial cells.
• To determine if inhibiting exportin 1 can attenuate NF-kappaB-mediated inflammatory gene expression.

Main Methods:

• Utilized leptomycin B to inhibit exportin 1 activity.
• Stimulated cells with IL-1beta.
• Assessed nuclear accumulation of NF-kappaB (Rel A) and IkappaBalpha via Western blotting and immunofluorescence.
• Measured NF-kappaB DNA binding activity.
• Quantified expression of inflammatory genes (monocyte chemoattractant protein, IL-8, intercellular adhesion molecule).

Main Results:

• Inhibition of exportin 1 led to nuclear accumulation of both NF-kappaB (Rel A) and IkappaBalpha.
• Pre-treatment with exportin 1 inhibitor prevented IL-1beta-induced increase in the nuclear NF-kappaB (Rel A)/IkappaBalpha ratio.
• Exportin 1 inhibition attenuated IL-1beta-induced NF-kappaB DNA binding and inflammatory gene expression.
• Exportin 1 inhibition reduced IL-1beta-induced IkappaBalpha phosphorylation without affecting IkappaB kinase activity.

Conclusions:

• Inhibition of exportin 1 effectively blocks NF-kappaB nuclear translocation and DNA binding in pulmonary microvascular endothelial cells.
• Increased nuclear IkappaBalpha concentration due to exportin 1 inhibition terminates NF-kappaB-mediated inflammatory gene expression.
• Targeting exportin 1 represents a potential therapeutic strategy for inflammatory diseases.